abstract |
the present invention relates to antibodies that specifically bind to cd137 (e.g., human cd137) and enhance the function of cd137. pharmaceutical compositions comprising such antibodies, nucleic acids encoding such antibodies, expression vectors and host cells for producing such antibodies, and methods of treating an individual using such antibodies are also provided. |